Neuroprotective effect of granulocyte colony-stimulating factor in a focal cerebral ischemic rat model with hyperlipidemia

Abstract

Granulocyte colony-stimulating factor (G-CSF) has been demonstrated to have neuroprotective effects in rat model with focal cerebral ischemia through anti-apoptotic pathways and by promoting proliferation of neural stem cells. In the present study, we examined the neuroprotective effect of G-CSF in an acute focal cerebral ischemia rat model with lipid metabolism disorder. Eighty male SD rats were randomly divided into normal diet control group (NC group) and high-fat diet group (HFD group) (n = 40 in each). In HFD group, rats were fed on high fat diet to induce atherosclerosis. After 29 days, 4 rats from each group were sacrificed to evaluate the effects of different diets, and the middle cerebral artery occlusion (MCAO) was performed in the rest of the rats. MCAO rats received either G-CSF (50 μg·kg⁻¹·mL⁻¹) or phosphate buffered saline (PBS) injection through the external jugular vein for 5 days, which was followed by 5-bromo-deoxy uridine (BrdU, i.p., 50 mg/kg) injection for another 7 days. To evaluate the effects of G-CSF treatment on neurological function, the modified neurological severity score (mNSS) was calculated. The vascular distribution, ischemic cells proliferation, cell apoptosis and the expression of vascular endothelial growth factor (VEGF) were measured to determine the effects of G-CSF treatment. Our results showed that G-CSF-treated rats had a lower mNSS than PBS-treated rats in both NC group and HFD group. G-CSF injection promoted endothelial cell proliferation and vascular regeneration, and inhibited cell apoptosis. The serum and tissue levels of VEGF were significantly increased after G-CSF treatment. It is concluded that G-CSF exerts its neuroprotective effect in focal cerebral ischemia rats with hyperlipidemia by enhancing angiogenesis, promoting cells proliferation, decreasing cell apoptosis, and increasing local VEGF expression.

Keywords

granulocyte colony-stimulating factor / hyperlipidemia / stroke / neuroprotection / vascular endothelial growth factor

References

[1] ZhangL., ShuX.J., ZhouH.Y., et al.. Protective effect of granulocyte colony-stimulating factor on intracerebral hemorrhage in rat. Neurochem Res, 2009, 34(7): 1317-1323

[2] SolarogluI., TsubokawaT., CahillJ., et al.. Antiapoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience, 2006, 143(4): 965-974

[3] BussolinoF., ZicheM., WangJ.M., et al.. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest, 1991, 87(3): 986-995

[4] SchäbitzW.R., KollmarR., SchwaningerM., et al.. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke, 2003, 34(3): 745-751

[5] Schneider A, Gümbel C, Sommer C, et al. GCSF: a brain-endogenous neuroprotective factor induced by focal cerebral ischemia. 13^th European Stroke Conference Mannheim-Heidelberg, Germany, 2004.

[6] ShyuW.C., LinS.Z., YangH.I., et al.. Functional recovery of stroke rats induced by granulocyte colony stimulating factor-stimulated stem cells. Circulation, 2004, 110(13): 1847-1854

[7] OrlicD., KajsturaJ., ChimentiS., et al.. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA, 2001, 98(18): 10 344-10 349

[8] ZhangZ.G., ZhangL., JiangQ., et al.. VEGF enhance angiogesis and promote blood-brain barrier leakage in the ischemic brain. J Clin Invest, 2000, 106(7): 829-838

[9] SchmidtaN.O., KoederaD., MessingaM., et al.. Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche. Brain Res, 2009, 1268(1): 24-37

[10] SanoJ.I., ShirakuraS., OdaS., et al.. Foam cells generated by a combination of hyperglycemia and hyperlipidemia in rats. Pathol Int, 2004, 54(12): 904-913

[11] XuS.W., FuJ.J., ChenJ.W., et al.. Development of an optimized protocol for primary culture of smooth muscle cells from rat thoracic aortas. Cytotechnology, 2009, 61(1–2): 65-72

[12] ZhangZ., ChoppM., ZhangR., et al.. A mouse model of embolic focal cerebral ischemia. J Cereb Blood Flow Metab, 1997, 17(10): 1081-1088

[13] ZhangR.L., ZhangZ.G., ZhangL., et al.. Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia. Neuroscience, 2001, 105(1): 33-41

[14] ChenJ., LiY., WangL., et al.. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke, 2001, 32(4): 1005-1011

[15] ChenJ., ZhangZ.G., LiY., et al.. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circulation Res, 2003, 92(6): 692-699

[16] SyroidD.E., MaycoxP.J., Soilu-HanninenM., et al.. Induction of postnatal Schwann cell death by the low-affinity neurotrophin receptor in vitro and after axotomy. J Neurosci, 2000, 20(15): 5741-5747

[17] KimH.K., SongK.S., ParkY.S., et al.. Elevated levels of circulating platelet microparticles, VEGF, IL-6, and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer, 2003, 39(17): 184-191

[18] ShifrenJ.L., DoldiN., FerraraN., et al.. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J Clin Endocrinol Metab, 1994, 79(1): 316-322

[19] TaguchiA., SomaT., TanakaH., et al.. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest, 2004, 114(3): 330-338

[20] SixI., GasanG., MuraE., et al.. Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur J Pharmacol, 2003, 458(3): 327-328

[21] MatchettG.A., CalinisanJ.B., MatchettG.C., et al.. The effect of granulocyte-colony stimulating factor in global cerebral ischemia in rats. Brain Res, 2007, 1136(1): 200-207

[22] ArakawaH., IkedaU., HojoY., et al.. Decreased serum vascular endothelial growth factor concentrations in patients with congestive heart failure. Heart, 2003, 89(2): 207-209

[23] Mata-GreenwoodE., MeyrickB., SoiferS.J., et al.. Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol, 2003, 285(1): L222-L231

[24] FrelinC., LadouxA., D’AngeloG.. Vascular endothelial growth factors and angiogenesis. Ann Endocrinol, 2000, 61(1): 70-74

[25] WollertK.C., MeyerG.P., LotzJ., et al.. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 2004, 364(9429): 141-148

[26] LiuY.P., SeckinH., IzciY., et al.. Neuroprotective effects of mesenchymal stem cells derived from human embryonic stem cells in transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab, 2009, 29(4): 780-791